On the nature of nondermatomal somatosensory deficits

Clinical Journal of Pain

Volumn 27, Issue 1, 2011, Pages 76-84

  Mailis Gagnon, Angela ^a,b   Nicholson, Keith ^a,b  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

conversion disorder; hysteria; NDSD; nondermatomal somatosensory deficits

Indexed keywords

ARTICLE; CLINICAL FEATURE; CONVERSION DISORDER; DEMOGRAPHY; DERMATOME; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HYSTERIA; NONDERMATOMAL SOMATOSENSORY DEFICIT; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOLOGICAL ASPECT; SOMATOSENSORY DISORDER; WORK RESUMPTION;

EID: 78650862205     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e3181e8d9cc     Document Type: Article

References (51)

1. Veith I. Hysteria. A History of a Disease. Chicago: University of Chicago Press; 1965.
2. Goetz CG, Bonduell M, Gelfand T. Charcot: Constructing Neurology. London: Oxford University Press; 1995.
3. Mailis A, Papagapiou M, Umana M, et al. Unexplainable nondermatomal somatosensory deficits in patients with chronic nonmalignant pain in the context of litigation/compensation: a role for involvement of central factors? J Rheumatol. 2001; 28:1385-1393.
4. Moriwaki K, Yuge O. Topographical features of cutaneous tactile hypoesthetic and hyperesthetic abnormalities in chronic pain. Pain. 1999;81:1-6.
5. Moriwaki K, Yuge O, Nishioka K, et al. Reduction in the size of tactile hypesthesia and allodynia closely associated with pain relief in patients with chronic pain. In: Gebhart GF, Hammond DL, Jensen TS, eds. Progress in Pain Research and Management. Vol. 2. Seattle, WA: IASP Press; 1994: 8l9-830.
6. Fishbain DA, Goldberg M, Meagher BR, et al. Male and female chronic pain patients categorized by DSM-III psychiatric diagnostic criteria. Pain. 1986;26:181-197.
7. Fishbain DA, Goldberg M, Rosomoff RS, et al. Chronic pain patients and the nonorganic physical signs of nondermatomal sensory abnormalities (NDSA). Psychosomatics. 1991;32: 294-303.
8. Fishbain DA, Cutler RB, Lewis J, et al. Is the location of nondermatomal sensory abnormalities (NDSAs) related to pain location? Pain Med. 2003;4:238-243.
9. Kaziyama HHS, Texeira MJ, Lin TY, et al. Fibromyalgia and Hemisensitive Syndromes [abstract]. IASP 9th World Congress in Pain, Vienna, Austria,1999: 550.
10. Rommel O, Gehling M, Dertwinkel R, et al. Hemisensory impairment in patients with complex regional pain syndrome. Pain. 1999;80:95-101.
11. Rommel O, Malina JP, Zenz M, et al. Quantitative sensory testing, neurophysiological and psychological examination in patients with complex regional pain syndrome and hemisen-sory deficits. Pain. 2001;93:279-293.
12. Arvantaj A, Mitrovich B, Lakha SF, et al. Characteristics of injured chronic pain workers identified by Workers Safety and Insurance Board (WSIB) staff as management problems [abstract]. Can Pain Soc Meeting, Pain Res Manage 2008;13:131.
13. Sa DS, Mailis-Gagnon A, Nicholson K, et al. Post-traumatic painful torticollis. Mov Disord. 2003;18:1482-1491.
14. Treede RD, Baron R. How to detect a sensory abnormality. Eur J Pain. 2008;12:395-396.
15. Mailis A, Nicholson K. The use of sodium amytal in the assessment and treatment of functional or other disorders. Phys Med Rehabil. 2002;16:131-146.
16. Cohodarevic T, Mailis A, Montanera W. Syringomyelia: pain, somatosensory abnormalities and neuroimaging. J Pain. 2000; 1:54-66.
17. Mailis A, Amani N, Umana M, et al. Effect of intravenous sodium amytal on cutaneous sensory abnormalities, spontaneous pain and algometric pain pressure thresholds in neuropathic pain patients: a placebo-controlled study. II. Pain. 1997;70:69-81.
18. Mailis-Gagnon A, Giannoylis I, Downar J, et al. Altered central somatosensory processing in chronic pain patients with "hysterical" anaesthesia. Neurology. 2003;60:1501-1507.
19. Chong MS, Smith TB, Hanna M. Case reports-reversal of sensory deficit associated with pain relief after treatment with gabapentin. Pain. 2002;96:329-333.
20. Apkarian AV, Stea RA, Bolanowski SJ. Heat-induced pain diminishes vibrotactile perception: a touch gate. Somatosens Mot Res. 1994;11:259-267.
21. Bolanowski SJ, Maxfield LM, Gescheider GA, et al. The effects of stimulus location on the gating of touch by heat- and cold-induced pain. Somatosens Mot Res. 2000;17: 195-204.
22. De Col R, Maihofner C. Centrally mediated sensory decline induced by differential C-fiber stimulation. Pain. 2008;138: 556-564.
23. Kosek E, Hansson P. The influence of experimental pain intensity in the local and referred pain area on somatosensory perception in the area of referred pain. Eur J Pain. 2002;6: 413-425.
24. Leffler AS, Kosek E, Hansson P. Injection of hypertonic saline into musculus infraspinatus resulted in referred pain and sensory disturbances in the ipsilateral upper arm. Eur J Pain. 2000;4:73-82.
25. Magerl W, Treede RD. Secondary tactile hypoesthesia: a novel type of pain-induced somatosensory plasticity in human subjects. Neurosci Lett. 2004;361:136-139.
26. Hansson P, Ekblom A, Lindblom A, et al. Does acute intraoral pain alter cutaneous sensibility? J Neurol Neurosurg Psychiatry. 1988;51:1032-1036.
27. Geber C, Magerl W, Fondel R, et al. Numbness in clinical and experimental pain-a cross-sectional study exploring the mechanisms of reduced tactile function. Pain. 2008;139: 73-81.
28. Kosek E, Ordeberg G. Abnormalities of somatosensory perception in patients with painful osteoarthritis normalize following successful treatment. Eur J Pain. 2000;4:229-238.
29. Leffler AS, Kosek E, Hansson P. The influence of pain intensity on somatosensory perception in patients suffering from subacute/chronic lateral epicondylalgia. Eur J Pain. 2000;4:57-71.
30. Leffler AS, Hansson P, Kosek E. Somatosensory perception in a remote pain-free area and function of diffuse noxious inhibitory controls (DNIC) in patients suffering from long-term trapezius myalgia. Eur J Pain. 2002;6:149-159.
31. Leffler AS, Hansson P, Kosek E. Somatosensory perception in patients suffering from long-term trapezius myalgia at the site overlying the most painful part of the muscle and in an area of pain referral. Eur J Pain. 2003;7:267-276.
32. Leffler AS, Kosek E, Lerndal T, et al. Somatosensory perception and function of diffuse noxious inhibitory controls (DNIC) in patients suffering from rheumatoid arthritis. Eur J Pain. 2002;6:161-176.
33. Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150:971-979.
34. Dostrovsky JO. Raphe and periaqueductal gray induced suppression of non-nociceptive neuronal responses in the dorsal column nuclei and trigeminal sub-nucleus caudalis. Brain Res. 1980;200:184-189.
35. Jundi AS, Saade NE, Banna NR, et al. Modification of transmission in the cuneate nucleus by raphe and peria-aqueductal gray stimulation. Brain Res. 1982;250:349-352.
36. Stammler T, De Col R, Seifert F, et al. Functional imaging of sensory decline and gain induced by differential noxious stimulation. Neuroimage. 2008;42:1151-1163.
37. Ghaffar O, Staines WR, Feinstein A. Unexplained neurologic symptoms: an fMRI study of sensory conversion disorder. Neurology. 2006;67:2036-2038.
38. Egloff N, Sabbioni ME, Salathe C, et al. Nondermatomal somatosensory deficits in patients with chronic pain disorder: clinical findings and hypometabolicd pattern in FDG-PET. Pain. 2009;145:252-258.
39. Vogt BA, Sikes RW, Vogt LJ. Anterior cingulate cortex and the medial pain system. In: Vogt BA, Gabriel M, eds. Neurobiology of Cingulate Cortex and Limbic Thalamus: A Comprehensive Handbook. Boston: Birkhiuser Pressedienst; 1993:313-344.
40. Mailis-Gagnon A, Israelson D. Beyond Pain. Toronto: Viking Canada; 2003:227.
41. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: Text Revision. 4th ed. Washington, DC: Author 2000.
42. Fishbain DA. Chronic nonmaligant pain. J Rheumatol. 2002; 29:22-43.
43. Fishbain DA, Cole B, Cutler RB, et al. A structured evidence-based review on the meaning of nonorganic physical signs: Waddell signs. Pain Med. 2003;4:141-181.
44. Waddell G, McCulloch JA, Kummel E, et al. Nonorganic physical signs in low-back pain. Spine. 1980;5:117-125.
45. Verdugo RJ, Ochoa JL. Reversal of hypoaesthesia by nerve block, or placebo: a psychologically mediated sign in chronic pseudoneuropathic pain patients. J Neurol Neurosurg Psychiatry. 1998;65:196-203.
46. Graham JR. MMPI-2: Assessing Personality and Psychopathology. 4th ed. New York: Oxford University Press; 2006.
47. Mailis A, Nicholson K. Effect of normal saline controlled intravenous administration of sodium amytal inpatients with pain and unexplainable widespread non-anatomical sensory deficits: a preliminary report. 16th annual APS meeting, New Orleans, American Pain Society Abstract 709:138, 1997.
48. Greve KW, Bianchini KJ, Ameduri CJ. The use of a forced-choice test of tactile discrimination in the evaluation of functional sensory loss: a report of 3 cases. Arch Phys Med Rehabil. 2003;84:1233-1236.
49. Mailis-Gagnon A, Nicholson K, Blumberger D, et al. Characteristics and period prevalence of self-induced disorder in patients referred to a pain clinic with the diagnosis of complex regional pain syndrome. Clin J Pain. 2008;24:176-185.
50. Marchettini P, Lacerenza M, Marangoni C, et al. Lidocaine test in neuralgia. Pain. 1992;48:377-382.
51. Nathan PW. Improvement in cutaneous sensibility associated with relief of pain. J Neurol Neurosurg Psychiatry. 1960;23:2002-2006.